系统性红斑狼疮患者淋巴细胞减少与中性粒细胞减少的独立关联:一项纵向多国研究
结果显示两者常见但关联因素不同:淋巴细胞减少与整体疾病活动、ESR、血清学及多种免疫抑制剂使用相关,中性粒细胞减少与MTX和环孢素负相关,狼疮低疾病活动状态与两者均负相关。
要点
- SLE患者中淋巴细胞减少(37.2%)比中性粒细胞减少(12.5%)更常见。
- 淋巴细胞减少与疾病活动、ESR、血清学及prednisolone、AZA、MTX、他克莫司、CYC、利妥昔单抗使用相关。
- 中性粒细胞减少与MTX和环孢素负相关,狼疮低疾病活动状态与两者均负相关。
核心结论
- 淋巴细胞减少和中性粒细胞减少在SLE患者中均常见,但与疾病和治疗变量的关联不同,应独立考虑。
研究设计与样本
- 基于亚太狼疮协作组前瞻性队列,2013至2018年收集疾病活动与用药数据,采用多重失败时间依赖生存分析。
主要发现
- 多变量分析后,淋巴细胞减少与整体疾病活动、ESR、血清学、prednisolone、AZA、MTX、他克莫司、CYC和利妥昔单抗使用相关。
- MTX和环孢素与中性粒细胞减少负相关;狼疮低疾病活动状态与淋巴细胞减少和中性粒细胞减少均负相关。
关键数值与推荐
- 淋巴细胞减少定义为淋巴细胞计数<0.8×10^9/l。
- 中性粒细胞减少定义为中性粒细胞计数<1.5×10^9/l。
临床怎么用
- 在SLE随访中应分别评估淋巴细胞减少和中性粒细胞减少,结合疾病活动与用药进行解读。
- 使用prednisolone、AZA、MTX、他克莫司、CYC或利妥昔单抗时需关注淋巴细胞减少风险。
- 达到狼疮低疾病活动状态可能降低淋巴细胞减少和中性粒细胞减少的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The prevalence and associations of leucopenia in SLE remain incompletely understood. We evaluated associations of disease activity and medication use with leucopenia (lymphopenia and neutropenia) in a multinational, prospectively followed SLE cohort. METHODS: Data from the Asia Pacific Lupus Collaboration cohort, in which disease activity and medications were prospectively captured from 2013 to 2018, were used. Predictors of lymphopenia (lymphocyte count <0.8 × 109/l) and neutropenia (neutrophil count <1.5 × 109/l) were examined using multiple failure, time-dependent survival analyses. RESULTS: Data from 2330 patients and 18 287 visits were analysed. One thousand and eighteen patients (43.7%) had at least one episode of leucopenia; 867 patients (37.2%) had lymphopenia, observed in 3065 (16.8%) visits, and 292 (12.5%) patients had neutropenia, in 622 (3.4%) visits. After multivariable analyses, lymphopenia was associated with overall disease activity, ESR, serology, prednisolone, AZA, MTX, tacrolimus, CYC and rituximab use. MTX and ciclosporin were negatively associated with neutropenia. Lupus low disease activity state was negatively associated with both lymphopenia and neutropenia. CONCLUSION: Both lymphopenia and neutropenia were common in SLE patients but were differentially associated with disease and treatment variables. Lymphopenia and neutropenia should be considered independently in studies in SLE.
引用
- Kandane-Rathnayake R, Louthrenoo W, Golder V, et al. Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study. Rheumatology (Oxford). 2021. PMID: 33693676. doi:10.1093/rheumatology/keab217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。